Skip to main content
. 2017 Sep 1;11(9):CC10–CC14. doi: 10.7860/JCDR/2017/29307.10633

[Table/Fig-4]:

Within group comparison of IDRS, QOL scale and glucose related parameters between controls, prediabetes and diabetes.

S. No Parameters Intervention Controls Prediabetes Diabetes
Group I
(n=59)
Group II
(n=60)
Group III
(n=61)
Group IV
(n=58)
Group V
(n=60)
1 IDRS Pre 44.93±9.53 73.00±7.88 74.59±6.21 74.91±7.35 75.33±6.50
Post 44.03±8.75 70.00±11.50* 57.21±10.19*** 67.02±8.86*** 58.67±10.16***
2 QoL scale Pre 90.29±5.60 74.17±6.49 73.79±6.35 66.56±7.08 66.78±7.30
Post 91.63±7.27 77.47±7.15** 85.62±5.77*** 70.81±7.13** 82.02±7.74***
3 Fasting Plasma Glucose (mg/dl) Pre 82.68±9.97 113.90±5.04 112.18±7.61 181.86±27.75 195.42±49.93
Post 83.90±9.49 111.43±6.73** 83.43±12.91*** 162.33±27.67** 152.33±31.26***
4 Fasting insulin (μIU/ml) Pre 5.74±2.20 20.87±7.06 21.27±6.70 32.48±9.53 32.02±9.06
Post 5.98±1.99 18.44±7.59** 12.01±5.94*** 27.07±8.14** 20.35±8.61***
5 HOMA-IR Pre 1.18±0.48 5.87±2.00 5.89±1.90 14.69±5.41 15.40±5.69
Post 1.25±0.46 5.10±2.16** 2.48±1.33*** 10.97±4.43** 7.54±3.21***

Data are expressed as mean±SD . Comparison of pre vs post is done by Student’s paired t test and p value is denoted by *. *p<0.05, **p<0.01, ***p<0.001. Group II and Group IV: Standard treatment; Group III and Group V: Yoga + Standard treatment.

IDRS: Indian diabetes risk score; QoL: Quality of life; HOMA-IR: Homeostatic model assessment of insulin resistance.